Uppsala Reports is the UMC's regular news bulletin for everyone concerned with the issues of pharmacovigilance. If you wish to go on the mailing list please send your details to email@example.com. Click on the links below for a pdf.
Uppsala Reports has undergone an intensive revamp over the past few months - just in time for its 20th birthday!
We’ve made many changes: a new design language and brand identity reflect the fact that the Uppsala Reports is a global entity and covers the whole world of pharmacovigilance. You’ll find new ideas for columns, new writers, new page designs, and a new spirit of inquiry that is both revolutionary and genuine. The latest edition of Uppsala Reports contains a wide range of news from around the world of pharmacovigilance, including regional initiatives from all corners of the globe.
As our main feature we interview Dr Andrea Marzi and put Ebola under the microscope, looking at developing an Ebola vaccine in the midst of an outbreak. We also examine the current trends in adverse drug reaction reporting and explore the recent UMC research paper “Quantitative benefit–risk assessment of methylprednisolone in multiple sclerosis relapses”.
Uppsala Reports is your magazine – just like it’s always been – and we would love to hear what you think about the new look; please e-mail us with comments and suggestions. (Please click on the image to get the 4.6Mb pdf.)
For all the previous issues of Uppsala Reports since 1996, click on Uppsala Reports Archive.
Uppsala Reports page last updated 16 May 2016
Uppsala Monitoring Centre · Tel: +46 18 65 60 60 · Fax: +46 18 65 60 88